• Wnt agonist 1: Workflows for Wnt Pathway Studies

  2026-09-24

  Use Wnt agonist 1 (BML-284) to probe β-catenin-dependent transcription and connect pathway activation to differentiation or cancer-cell phenotypes. This workflow pairs dose-and-time optimization with orthogonal readouts, including a carefully bounded approach to investigating the Wnt/NR2F2/GPX4 axis reported in lung cancer brain metastasis.

• GSK 2837808A in Lactate-Pathway Research

  2026-09-24

  Use GSK 2837808A to test whether LDHA-dependent lactate production drives metabolic phenotypes in cancer cells, with practical readouts that distinguish lactate changes from general loss of viability. Its established hepatocellular carcinoma context makes it a useful starting point for carefully bounded, hypothesis-generating studies of the NAT1–ENO1–lactate pathway in colorectal cancer.

• Anlotinib Suppresses Angiogenic Receptor Signaling

  2026-09-23

  The 2018 study examined how anlotinib limits angiogenesis induced by VEGF, PDGF-BB, and FGF-2, linking functional effects in endothelial and tissue-based assays to inhibition of VEGFR2, PDGFRβ, FGFR1, and ERK signaling. Its multi-model design supports further investigation of anlotinib as an anti-angiogenic research tool, while leaving clinical efficacy and the relative contribution of each target open for study.

• AG-221 Enasidenib Workflow for IDH2 AML

  2026-09-23

  Use AG-221 (Enasidenib) to connect mutant IDH2 activity with 2-hydroxyglutarate reduction, leukemia cell differentiation, and metabolic rewiring in controlled AML experiments. This workflow combines genotype-matched controls, metabolite analysis, and CD44-focused follow-up assays to distinguish on-target biology from nonspecific toxicity.

• CKI 7 Dihydrochloride: CK1 Inhibitor Guide

  2026-09-22

  CKI 7 dihydrochloride is a Casein kinase 1 inhibitor used to investigate ATP-dependent CK1 phosphorylation in Wnt, circadian, DNA-repair, and cancer models. It is a research reagent, not a validated inhibitor of the MAPK10–KRT16 axis described in recent NSCLC research.

• IWR-1-endo for Wnt-Driven Assay Design

  2026-09-22

  IWR-1-endo provides a mechanism-led way to suppress β-catenin accumulation in colorectal cancer, regenerative, and exploratory cardiomyocyte phenotyping workflows. Its Axin-dependent action can complement high-content morphological profiling by separating Wnt-responsive phenotypes from pathway-independent changes.

• GSK-923295: Reliable Mitosis Assay Design

  2026-09-21

  This scenario-driven guide explains how GSK-923295, SKU A3450, can improve interpretation of cell-growth, viability, and mitotic phenotypes. It connects CENP-E biology with formulation, dose planning, microscopy, vendor selection, and translational limits.

• K+ Channel Blockade and Renal Blood Flow in Sepsis

  2026-09-21

  This study examined how blocking Kir6.1 ATP-sensitive and KCa1.1 calcium-activated potassium channels changes renal vascular responses to norepinephrine and phenylephrine in septic rats. Its key contribution was to show that channel blockade may have little effect on basal renal blood flow yet markedly worsen pressor-associated hypoperfusion, highlighting the context dependence of the septic vasodilation pathway.

• High-Content Stem Cell Screening in Schistosomula

  2026-09-20

  Perera, Chioni, and Walker developed a quantitative high-content platform that measures somatic neoblast proliferation in developmentally advanced liver-stage Schistosoma mansoni schistosomula. Screening a 280-compound stem-cell-focused collection identified prioritized molecules that disrupted parasite development and stem cell proliferation, providing new anti-schistosomal leads and a mechanistic screening framework.

• Anlotinib hydrochloride: Angiogenesis Workflow

  2026-09-19

  Build a reproducible angiogenesis assay cascade around Anlotinib hydrochloride, from endothelial migration and tube formation to receptor-level validation. This workflow pairs multi-target pharmacology with practical controls, dose selection, and troubleshooting for cancer research.

• 25-Hydroxycholesterol, AMPK, and TAM Reprogramming

  2026-09-18

  Xiao et al. identify CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint that links lysosomal lipid sensing to AMPKα–STAT6 signaling in tumor-associated macrophages. The study shows how disrupting this pathway can improve T-cell surveillance and enhance anti-PD-1 responses, while defining a mechanistic framework for testing AMPK-dependent metabolic reprogramming.

• gamma-Glu-Cys: Glutathione Pathway Research Guide

  2026-09-18

  gamma-Glu-Cys, also written γ-Glu-Cys, is a defined intermediate used to study glutathione biosynthesis and glutathione synthetase activity. The B7887 product dossier reports a molecular weight of 250.27 g/mol, approximately 98% HPLC/MS/NMR-confirmed purity, high solvent solubility, and storage at −20°C.

• PF-562271 HCl as a Metastatic-Niche Probe

  2026-09-17

  PF-562271 HCl offers a powerful way to study how FAK/Pyk2 signaling may shape metastatic-niche biology beyond tumor-cell proliferation. This article connects its reversible kinase inhibition with recent evidence on circulating phagocytic polyploid giant cancer macrophages and proposes a more informative assay framework for cancer research.

• Measuring Drug Response Beyond Relative Viability

  2026-09-17

  Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability to separate growth inhibition from actual cancer-cell killing. This framework improves interpretation of in vitro drug responses by integrating response magnitude with the timing and balance of cytostatic and cytotoxic effects.

• CHIR-99021 for Stem Cell Fate Workflows

  2026-09-16

  CHIR-99021 (CT99021) gives researchers a tunable way to activate Wnt/β-catenin signaling while testing pluripotency, cardiac, and neuronal fate decisions. This workflow connects GSK-3 inhibition with the 2024 AGO1 protein-folding study to improve controls, timing, readouts, and troubleshooting in mouse and human stem cell models.

7895 records 1/527 page Next 12345 下5页 Last page